You are here

Roche

Esmo 2019 preview – immunotherapies grab the rest of the late-breaker focus

EP Vantage

Tue, 09/10/19 - 11:49 pm

What could help biotech close out 2019 stronger? Analysts pick 3 events to watch

Biopharma Dive

Sat, 09/7/19 - 06:38 pm

KRAS inhibitors

PTC Therapeutics

Who will be the biggest pharma players in orphan drugs?

Pharmaforum

Sat, 09/7/19 - 06:25 pm

Roche boosts cancer approvals in Europe, pushing for a bigger slice of the I/O pie

Endpoints

Fri, 09/6/19 - 10:09 am

non-squamous cell non-small cell lung cancer

Roche stays mum about FTC, CMA reviews as $4.3B Spark deal faces yet another delay. What's up?

Endpoints

Tue, 09/3/19 - 10:56 am

Spark Therapeutics

Roche’s Xofluza limits spread of flu virus, says new study

Pharmaforum

Mon, 09/2/19 - 12:09 pm

clinical trials

Novartis takes aim at Roche's star MS drug

Reuters

Fri, 08/30/19 - 10:08 am

multiple sclerosis

Does competition equal lower prices? MS drugs defied cost logic as challengers swarmed in

Fierce Pharma

Thu, 08/29/19 - 08:18 pm

multiple sclerosis

Teva Pharmaceutical

EMA follows FDA to approve Roche's Tecentriq combo for frontline use in triple negative breast cancer

Endpoints

Thu, 08/29/19 - 12:26 pm

triple negative breast cancer

Mark Your Calendar For These September PDUFA Dates

Yahoo/Benzinga

Wed, 08/28/19 - 12:53 pm

Xeris Pharmaceuticals

Amgen biosimilar debut boosted by UnitedHealthcare coverage switch

Biopharma Dive

Mon, 08/19/19 - 11:52 am

UnitedHealthcare

Roche cancer treatment priced at $17,050 a month, lower than rival Vitrakvi

Reuters

Sat, 08/17/19 - 12:08 am

personalized medicine

Four New Drugs are Around the Corner. Here’s What You Need to Know.

Xconomy

Thu, 08/15/19 - 11:39 pm

Sarepta Therapeutics

Nabriva Therapeutics

Roche scores double cancer approval for new Bayer rival Rozlytrek

Fierce Pharma

Thu, 08/15/19 - 11:32 pm

NTRK fusion-positive tumors

non-small cell lung cancer

Roche Expands Global Access to Viral Assays to Aid Eradication Efforts

Medical Devices and Diagnostics Industry

Fri, 08/9/19 - 07:42 pm

Global Access Program

Roche says test showed Tecentriq helped vs bladder cancer

Reuters

Mon, 08/5/19 - 11:03 am

Thrashed by a 'surprise' rival, Sanofi writes off $2B on soured hemophilia deal

Endpoints

Mon, 07/29/19 - 09:39 am

Go or no go? Abbvie, Roche and Kala await key decisions

EP Vantage

Fri, 07/26/19 - 11:04 am

Kala Pharmaceuticals

dry eye disease

Roche (RHHBY) 1H19 Earnings & Sales Up Y/Y, View Raised

Yahoo/Zacks.com

Thu, 07/25/19 - 10:37 am

Roche axes early-phase inflammatory disease drug

Fierce Biotech

Thu, 07/25/19 - 10:31 am

inflammatory diseases

Pages